Papers

7

Total Citations

106

H-Index

6

About

Hongda Zhu is a thoracic surgeon and clinical researcher whose work centers on minimally invasive surgical approaches for non-small cell lung cancer (NSCLC), with a particular focus on comparing robotic-assisted thoracoscopic surgery (RATS) and video-assisted thoracoscopic surgery (VATS). His research has made significant contributions to understanding the perioperative and oncological outcomes of these techniques across diverse patient populations, including elderly patients aged 75 and older, octogenarians, young adults, and those undergoing neoadjuvant immunochemotherapy. Zhu's propensity score-matched studies provide rigorous real-world evidence that helps clinicians determine the optimal surgical strategy for specific patient subgroups, accumulating over 100 citations across his published work. Notably, he has investigated the feasibility of China's domestically developed Toumai® surgical robot alongside the widely used da Vinci system, contributing to the advancement of homegrown surgical technology. His 2024 examination of lymph node dissection quality and early recurrence in stage N1-2 NSCLC over an eleven-year dataset from a high-volume center underscores his commitment to longitudinal, practice-changing research. Zhu's body of work serves as an essential resource for surgeons and oncologists navigating the rapidly evolving landscape of thoracic cancer surgery.

Research Focus

Key Achievements

6
H-Index
7
Papers
106
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Propensity score-matched comparison of robotic- and video-assisted thoracoscopic surgery, and open lobectomy for non-small cell lung cancer patients aged 75 years or older
26 citations · 2022
📈 Most Prolific Year: 2023 (4 Papers)
🤝 Key Collaborators: 30
🏛 Institutions: Shanghai Jiao Tong University, Shanghai Chest Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago